Adamant Health Oy

📍 Kuopio, Finland🗓 Founded 2020👥 19 employees💰 Last funded May 2022
We are helping people with Parkinsons disease by providing an accurate and clear picture of their condition to get the best treatment possible, improving their quality of life. Adamant Health is a Finnish health-tech startup on a mission to revolutionize the care of Parkinson’s disease by enabling data-driven disease management, supporting earlier diagnosis and improving patient outcomes. The company was founded in 2020 as a spin-off from the University of Eastern Finland to bring our research-based, innovative technology to patients, clinicians, healthcare service providers and companies developing new therapies. We have developed the first, advanced precision technology able to measure the visible and invisible motor symptoms of Parkinsons disease. Our unique CE-marked data-analysis technology, based on surface electromyography (EMG), provides detailed and accurate symptom data, essential for supporting personalised treatment that can be continuously optimised. The technology is based on over 15 years of research with more than 25 scientific articles published in international publications. In addition to Parkinsons disease, our technology brings also visibility to the symptoms of various other movement disorders.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded
Investor geography1 country
Finland
1
Frequently asked questions
Who invested in Adamant Health Oy?
Adamant Health Oy has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Adamant Health Oy last raise funding?
The most recent investment in Adamant Health Oy recorded on gritt.io was in May 2022.
When was Adamant Health Oy founded?
Adamant Health Oy was founded in 2020.
What industry is Adamant Health Oy in?
Adamant Health Oy operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Adamant Health Oy based?
Adamant Health Oy is headquartered in Kuopio, Finland.